The combination of both drugs 5 μM VCR + 1.5 μM brusatol induced a potent proapoptotic response in B-ALL cells, as seen by a significant increase in the number of apoptotic cells (by Annexin-V/PI staining) (Figures 2E, F). The gene discussed is ANXA5; the disease is acute lymphoblastic leukemia.